🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I dose escalation and expansion trial. The purpose of this ...
Status
Recruiting
Location
Huntsman Cancer Institute
Start Date
2015-05-07
Trial ID
NCT02390518
Treatments Being Tested
Evaluation of the safety and tolerability of immune-targeted therapy combin...
Status
Recruiting
Location
West China Hospital, Sichuan University
Start Date
2024-12-15
Trial ID
NCT06741982
Treatments Being Tested
This is a phase I/II, open-label, dose-escalation study designed to evaluat...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2019-08-13
Trial ID
NCT04077723
Treatments Being Tested
The trial aims to evaluate the long-term clinical outcome of the DCB-only t...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2021-06-30
Trial ID
NCT04842838
Treatments Being Tested
The goal of this clinical trial is to learn if NDI-219216 is safe for patie...
Status
Recruiting
Location
USC Norris Comprehensive Cancer Center
Start Date
2025-03-31
Trial ID
NCT06898450
Treatments Being Tested
This study is to assess the safety and antitumor activity of ABL103 plus pe...
Status
Recruiting
Location
UH Cleveland Medical Center
Start Date
2025-08-06
Trial ID
NCT07158918
Treatments Being Tested
This study will assess the dentoalveolar effects and impact on quality of l...
Status
Completed
Location
Pontifícia Universidade Católica de Minas Gerais
Start Date
2018-12-01
Trial ID
NCT03846518
Treatments Being Tested
This is a multicenter, open-label, single-arm study to investigate the safe...
Status
Completed
Location
The Angeles Clinic and Research Institute
Start Date
2023-01-05
Trial ID
NCT05577182
Treatments Being Tested
To evaluate the safety, tolerability, and DLTs and determine the MTD and/or...
Status
Recruiting
Location
The Angeles Clinic and Research Institute
Start Date
2023-07-24
Trial ID
NCT05836324
This study is to evaluate a novel cytotoxic anti-PD-L1, IUAb190708, for the...
Status
Recruiting
Location
Fujian Cancer Hospital
Start Date
2024-06-18
Trial ID
NCT07584954
Treatments Being Tested